CordainLLindebergSHurtadoMHillKEatonSBBrand-MillerJ.Acne vulgaris: a disease of western civilization. Arch Dermatol. 2002;138(12):1584-1590.
2.
RademakerMGariochJJSimpsonNB.Acne in school children: no longer a concern for dermatoloigsts. BMJ. 1989;298:1217-1219.
3.
KilkennyMMerlinKPlunkettAMarksR.The prevalence of common skin conditions in Australian school students, III: acne vulgaris. Br J Dermatol. 1998;139:840-845.
4.
LelloJPearlAArrollBYallopJBirchallNM.Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J. 1995;108:287-289.
5.
ZhouCVempatiATamC, et al. Beyond the surface: a deeper look at the psychosocial impacts of acne scarring. Clin Cosmet Investig Dermatol. 2023;16:731-738.
6.
HazarikaNArchanaM.The psychosocial impact of acne vulgaris. Indian J Dermatol. 2016;61(5):515-520.
7.
ToyodaMMorohashiM.Pathogenesis of acne. Med Electron Microsc. 2001;34(1):29-40.
8.
Anina LambrechtsINuno de CanhaMLallN. Exploiting medicinal plants as possible treatments for acne vulgaris. In: LallN, ed. Medicinal Plants for Holistic Health and Well-Being. Amsterdam, The Netherlands: Elsevier; 2018:117-143. doi:10.1016/b978-0-12-812475-8.00004-4
9.
ThiboutotDM.The role of follicular hyperkeratinization in acne. J Dermatol Treat. 2000;11(2):5-8. doi:10.1080/095466300750163645
10.
GhoshSChaudhuriSJainVKAggarwalK.Profiling and hormonal therapy for acne in women. Indian J Dermatol. 2014;59(2):107-115. doi:10.4103/0019-5154.127667
11.
BlumFRNiemanELMcShaneDBMorrellDS. Pediatric dermatology and common skin conditions. In: Halpern-FelsherB, ed. Encyclopedia of Child and Adolescent Health. Amsterdam, The Netherlands: Elsevier; 2023:699-732. doi:10.1016/b978-0-12-818872-9.00093-5
12.
ZouboulisCCJourdanEPicardoM.Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527-532. doi:10.1111/jdv.12298
13.
McLaughlinJWattersonSLaytonAMBjoursonAJBarnardEMcDowellA.Propionibacterium acnes and acne vulgaris: new insights from the integration of population genetic, multi-omic, biochemical and host-microbe studies. Microorganisms. 2019;7(5):128. doi:10.3390/microorganisms7050128
14.
KwonHHYoonJYHongJSJungJYParkMSSuhDH.Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial. Acta Derm Venereol. 2012;92(3):241-246.
15.
CermanAAAktaşEAltunayIKArıcıJETulunayAOzturkFY.Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris. J Am Acad Dermatol. 2016;75(1):155-162.
16.
AdebamowoCASpiegelmanDDanbyFWFrazierALWillettWCHolmesMD.High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005;52(2):207-214.
17.
AdebamowoCASpiegelmanDBerkeyCS, et al. Milk consumption and acne in adolescent girls. Dermatol Online J. 2006;12(4):1.
18.
AdebamowoCASpiegelmanDBerkeyCS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008;58(5):787-793.
19.
Di LandroACazzanigaSParazziniF, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol. 2012;67(6):1129-1135.
20.
IsmailNHManafZAAzizanNZ.High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study. BMC Dermatol. 2012;12:13.
21.
DaiRHuaWChenWXiongLLiL.The effect of milk consumption on acne: a meta-analysis of observational studies. J Eur Acad Dermatol Venereol. 2018;32(12):2244-2253. doi:10.1111/jdv.15204
22.
AghasiMGolzarandMShab-BidarSAminianfarAOmidianMTaheriF.Dairy intake and acne development: a meta-analysis of observational studies. Clin Nutr. 2019;38(3):1067-1075. doi:10.1016/j.clnu.2018.04.015
AchermannYGoldsteinEJCoenyeTShirtliffME.Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27(3):419-440.
25.
ElstonMJDupaixJPOpanovaMIAtkinsonRE.Cutibacterium acnes (formerly propionibacterium acnes) and shoulder surgery. Hawaii J Health Soc Welf. 2019;78(11)(suppl 2):3-5.
26.
MayslichCGrangePADupinN.Cutibacterium acnes as an opportunistic pathogen: an update of its virulence-associated factors. Microorganisms. 2021;9(2):303. doi:10.3390/microorganisms9020303
27.
TaxGUrbánEPalotásZ, et al. Propionic acid produced by propionibacterium acnes strains contributes to their pathogenicity. Acta Derm Venereol. 2016;96(1):43-49. doi:10.2340/00015555-2154
28.
PlatsidakiEDessiniotiC.Recent advances in understanding Propionibacterium acnes ( Cutibacterium acnes) in acne. F1000Res. 2018;7:F1000 Faculty Rev-1953. doi:10.12688/f1000research.15659.1
29.
AlexeyevOADekioILaytonAM, et al. Why we continue to use the name Propionibacterium acnes. Br J Dermatol. 2018;179(5):1227.
HandelsmanDJ. Androgen physiology, pharmacology, use | misuse. In: FeingoldKRAnawaltBBlackmanMR, et al., eds. Endotext. South Dartmouth, MA: MDText.com, Inc; 2000. https://www.ncbi.nlm.nih.gov/books/NBK279000/
32.
DingHZhangJZhangF.Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol. 2021;12:741764. doi:10.3389/fendo.2021.741764
33.
HiortO.Androgens and puberty. Best Pract Res Clin Endocrinol Metab. 2002;16(1):31-41. doi:10.1053/beem.2002.0178
34.
PetridisCNavariniAADandN, et al. Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne. Nat Commun. 2018;9(1):5075. doi:10.1038/s41467-018-07459-5
35.
BatailleVSniederHMacGregorAJSasieniPSpectorTD.The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol. 2002;119(6):1317-1322. doi:10.1046/j.1523-1747.2002.19621.x
36.
HengAHSSayYHSioYY, et al. Gene variants associated with acne vulgaris presentation and severity: a systematic review and meta-analysis. BMC Med Genomics. 2021;14:103. doi:10.1186/s12920-021-00953-8
37.
DrénoBBettoliVAraviiskaiaESanchez VieraMBoulocA.The influence of exposome on acne. J Eur Acad Dermatol Venereol. 2018;32(5):812-819. doi:10.1111/jdv.14820
38.
SchromKPAhsanuddinSBaechtoldMTripathiRRamserABaronE.Acne severity and sleep quality in adults. Clocks Sleep. 2019;1(4):510-516. doi:10.3390/clockssleep1040039
39.
AlshammrieFFAlshammariRAlharbiRMKhanFHAlshammariSK.Epidemiology of acne vulgaris and its association with lifestyle among adolescents and young adults in Hail, Kingdom of Saudi Arabia: a community-based study. Cureus. 2020;12(7):e9277. doi:10.7759/cureus.9277
40.
RouhaniPBermanB, et al. Poster 706: acne improves with a popular, low glycemic diet from South Beach. J Am Acad Dermatol. 2009;60(3)(suppl 1):AB14.
41.
SmithRNMannNJBraueAMäkeläinenHVarigosGA.The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007;57(2):247-256.
42.
CengizFPCevirgen CemilBEmirogluNGulsel BahaliAOnsunN.Acne located on the trunk, whey protein supplementation: is there any association?Health Promot Perspect. 2017;7(2):106-108. doi:10.15171/hpp.2017.19
43.
PontesTdCFernandes FilhoGMTrindadeAdSSobral FilhoJF. Incidence of acne vulgaris in young adult users of protein-calorie supplements in the city of João Pessoa–PB. An Bras Dermatol. 2013;88(6):907-912. doi:10.1590/abd1806-4841.20132024
44.
SimonartT.Acne and whey protein supplementation among bodybuilders. Dermatology. 2012;225(3):256-258. doi:10.1159/000345102
45.
ChoiJMLewVKKimballAB.A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris. Pediatr Dermatol. 2006;23(5):421-427. doi:10.1111/j.1525-1470.2006.00276.x
46.
KraftJFreimanA.Management of acne. CMAJ. 2011;183(7):E430-E435. doi:10.1503/cmaj.090374
47.
TitusSHodgeJ.Diagnosis and treatment of acne. Am Fam Physician. 2012;86(8):734-740.
48.
TobiaszANowickaDSzepietowskiJC.Acne vulgaris-novel treatment options and factors affecting therapy adherence: a narrative review. J Clin Med. 2022;11(24):7535. doi:10.3390/jcm11247535
49.
MotamediMChehadeASangheraRGrewalP.A clinician’s guide to topical retinoids. J Cutan Med Surg. 2022;26(1):71-78. doi:10.1177/12034754211035091
50.
BasakSAZaengleinAL.Acne and its management. Pediatr Rev. 2013;34(11):479-497. doi:10.1542/pir.34-11-479
51.
LeungAKBarankinBLamJMLeongKFHonKL.Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10. doi:10.7573/dic.2021-8-6
52.
OtlewskaABaranWBatycka-BaranA.Adverse events related to topical drug treatments for acne vulgaris. Expert Opin Drug Saf. 2020;19(4):513-521. doi:10.1080/14740338.2020.1757646
53.
OngeESMobleyWC.Minocycline topical foam: a new drug for the treatment of acne. Ann Pharmacother. 2021;55(1):105-110. doi:10.1177/1060028020939926
54.
AshtonRWeinsteinM.Acne vulgaris in the pediatric patient. Pediatr Rev. 2019;40(11):577-589. doi:10.1542/pir.2018-0137
55.
AdlerBLKornmehlHArmstrongAW.Antibiotic resistance in acne treatment. JAMA Dermatol. 2017;153(8):810-811. doi:10.1001/jamadermatol.2017.1297
56.
LeungAKCBarankinBHonKL. Adolescent acne vulgaris: an overview of therapeutic options. Consultant Pediatr. 2015;14:63-65.
57.
ZaengleinALThiboutotDM.Expert committee recommendations for acne management. Pediatrics. 2006;118(3):1188-1199. doi:10.1542/peds.2005-2022
58.
ZaengleinAL. Acne vulgaris. N Engl J Med. 2018;379(14):1343-1352. doi:10.1056/NEJMcp1702493
59.
OgéLKBroussardAMarshallMD.Acne vulgaris: diagnosis and treatment. Am Fam Physician. 2019;100(8):475-484.
60.
KosmadakiMKatsambasA.Topical treatments for acne. Clin Dermatol. 2017;35(2):173-178. doi:10.1016/j.clindermatol.2016.10.010
61.
HayashiNAkamatsuHIwatsukiK, et al. Japanese Dermatological Association Guidelines: guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018;45(8):898-935. doi:10.1111/1346-8138.14355
62.
LiuHYuHXiaJ, et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev. 2020;5(5):CD011368. doi:10.1002/14651858.CD011368.pub2
63.
FoxLCsongradiCAucampMdu PlessisJGerberM.Treatment modalities for acne. Molecules. 2016;21(8):1063. doi:10.3390/molecules21081063
Stein GoldLBaldwinHKircikLH, et al. Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug. Am J Clin Dermatol. 2022;23(1):93-104. doi:10.1007/s40257-021-00650-3
66.
GriffinMOFricovskyECeballosG, et al. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol. 2010;299(3):C539-C548.
67.
LeydenJJDel RossoJQ.Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol. 2011;4(2):40-47.
Del RossoJQ. Oral Doxycycline in the management of acne vulgaris: current perspectives on clinical use and Rerent findings with a new double-scored small tablet formulation. J Clin Aesthet Dermatol. 2015;8(5):19-26.
70.
OchsendorfF.Minocycline in acne vulgaris: benefits and risks. Am J Clin Dermatol. 2010;11(5):327-341.
MarsonJWBaldwinHE.An overview of acne therapy, part 1: topical therapy, oral antibiotics, laser and light therapy, and dietary interventions. Dermatol Clin. 2019;37(2):183-193.
73.
GuzmanAKChoiJKJamesWD.Safety and effectiveness of amoxicillin in the treatment of inflammatory acne. Int J Womens Dermatol. 2018;4(3):174-175. doi:10.1016/j.ijwd.2018.03.006
74.
SłopieńRMilewskaERynioPMęczekalskiB.Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Prz Menopauzalny. 2018;17(1):1-4. doi:10.5114/pm.2018.74895
75.
TrivediMKShinkaiKMuraseJE.A review of hormone-based therapies to treat adult acne vulgaris in women. Int J Womens Dermatol. 2017;3(1):44-52. doi:10.1016/j.ijwd.2017.02.018
76.
TylerKHZirwasMJ.Contraception and the dermatologist. J Am Acad Dermatol. 2013;68(6):1022-1029.
77.
SanterMLawrenceMRenzS, et al. SAFA trial investigators. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023;381:e074349. doi:10.1136/bmj-2022-074349
78.
ArmaniniDAndrisaniABordinLSabbadinC.Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother. 2016;17:1713-1715.
79.
RobertsEENowsheenSDavisDMRHandJLTollefsonMMWetterDA.Use of spironolactone to treat acne in adolescent females. Pediatr Dermatol. 2021;38(1):72-76. doi:10.1111/pde.14391
80.
ShawJCWhiteLE.Long-term safety of spironolacone in acne: results of an 8 year follow-up study. J Cut Med and Surg. 2002;12:541-545.
81.
CunliffeWJVan de KerkhofPCCaputoR, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology. 1997;194(4):351-357. doi:10.1159/000246134
82.
SkrozaNTolinoEBalduzziV, et al. Advantages of tailored isotretinoin treatment in moderate to severe acne: real-life data. Front Pharmacol. 2021;12:733526. doi:10.3389/fphar.2021.733526
83.
BagatinECostaCS.The use of isotretinoin for acne—an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020;13(8):885-897. doi:10.1080/17512433.2020.1796637
84.
CoatesPAdamsCACunliffeWJ, et al. Does oral isotretinoin prevent Propionibacterium acnes resistance. Dermatology. 1997;195(suppl 1):4-9; discussion 38-40. doi:10.1159/000246012
85.
DispenzaMCWolpertEBGillilandKL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132(9):2198-2205. doi:10.1038/jid.2012.111
LeeKCBercovitchL.Circumventing iPLEDGE: circumventing ethical responsibility?J Am Acad Dermatol. 2017;77(6):1185-1187.
88.
CrockettSDPorterCQMartinCFSandlerRSKappelmanMD.Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2010;105(9):1986-1993. doi:10.1038/ajg.2010.124
89.
SingerSTkachenkoESharmaPBarbieriJSMostaghimiA.Psychiatric adverse events in patients taking isotretinoin as reported in a food and drug administration database from 1997 to 2017. JAMA Dermatol. 2019;155(10):1162-1166. doi:10.1001/jamadermatol.2019.1416
90.
DiogoMLGCamposTMFonsecaESR, et al. Effect of Blue light on acne vulgaris: a systematic review. Sensors. 2021;21(20):6943. doi:10.3390/s21206943
91.
MeløTB.Uptake of protoporphyrin and violet light photodestruction of propionibacterium acnes. Z Naturforsch C J Biosci. 1987;42(1-2):123-128.
92.
McGinleyKJWebsterGFLeydenJJ.Facial follicular porphyrin fluorescence: correlation with age and density of propionibacterium acnes. Br J Dermatol. 1980;102(4):437-441.
93.
ScottAMStehlikPClarkJ, et al. Blue-light therapy for acne vulgaris: a systematic review and meta-analysis. Ann Fam Med. 2019;17(6):545-553.
94.
NakayamaEKushibikiTMayumiY, et al. Optimal blue light irradiation conditions for the treatment of acne vulgaris in a mouse model. J Photochem Photobiol B. 2023;239:112651. doi:10.1016/j.jphotobiol.2023.112651
95.
BonnansMFouqueLPelletierM, et al. Blue light: friend or foe?J Photochem Photobiol B. 2020;212:112026. doi:10.1016/j.jphotobiol.2020.112026
96.
KwonHLeeJYoonJ, et al. The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br J Dermatol. 2012;168:1088-1094.
97.
ElmanMLebzelterJ.Light therapy in the treatment of acne vulgaris. Dermatol Surg. 2004;30(2, pt 1):139-146. doi:10.1111/j.1524-4725.2004.30053.x
98.
WanMTLinJY.Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol. 2014;7:145-163. doi:10.2147/CCID.S35334
99.
WojewodaKGillstedtMToviJ, et al. Optimizing treatment of acne with photodynamic therapy (PDT) to achieve long-term remission and reduce side effects. A prospective randomized controlled trial. J Photochem Photobiol B. 2021;223:112299. doi:10.1016/j.jphotobiol.2021.112299
100.
AkaraphanthRKanjanawanitchkulWGritiyarangsanP.Efficacy of ALA-PDT vs blue light in the treatment of acne. Photodermatol Photoimmunol Photomed. 2007;23(5):186-190. doi:10.1111/j.1600-0781.2007.00303.x
101.
WiegellSRWulfHC.Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006;154(5):969-976. doi:10.1111/j.1365-2133.2005.07107.x
